AstraZeneca joins Pfizer in MFN pricing deal with US AstraZeneca has become the second pharma group to reach an agreement with the Trump administration on Most Favoured Nation (MFN) drug pricing.

#Pfizer #MFN #MFNPricing #USA #Trump #mostfavourednationdeal #MFNdeal #prescriptiondrugs #pharmatariffs #pharmainvestments #pharmaceuticalmanufacturing #pharmaRandD #TrumpRx #pharmacompanies #MFNsystem #referencepricing #priceofmedicines #brandedpharmaceuticals #generics
zurl.co/8wpiu

#ISPORAnnual Virginia Acha notes that tough pricing regulation in the US will reduce incentives for investment in innovation - and this is a double whammy if coupled with reduced US funding of basic science.
#referencepricing #HealthEconomics